Caplight Directory>Investors>Octagon Capital>Octagon-capital-1


Octagon Capital

Octagon Capital

—octagoninvest.com

Overview

A multi-stage investment manager founded in 2019 that is dedicated to evidence-based investing in public and private healthcare companies, with a focus on the United States and China. The firm strives to build concentrated, long-term investments and partners with its portfolio companies. It manages capital for global institutions such as university endowments, non-profit foundations, family offices, and pension funds.

Year Founded

2019

AUM

$951.8M

Portfolio Companies

30

Investments

CompanyDateStageLead
Palisade BioOct 2025Follow-on OfferingCo-investor
Aktis OncologySep 2024Series BCo-investor
Bluejay TherapeuticsMay 2024Series CCo-investor
Profound BioFeb 2024Series BCo-investor
Tenaya TherapeuticsFeb 2024Follow-on OfferingCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters—
Year Founded2019
AUM$951.8M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.